Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 479

1.

The biology of VEGF and its receptors.

Ferrara N, Gerber HP, LeCouter J.

Nat Med. 2003 Jun;9(6):669-76. Review.

PMID:
12778165
2.

Role of vascular endothelial growth factor in regulation of physiological angiogenesis.

Ferrara N.

Am J Physiol Cell Physiol. 2001 Jun;280(6):C1358-66. Review.

3.

The role of vascular endothelial growth factor in angiogenesis.

Ferrara N, Gerber HP.

Acta Haematol. 2001;106(4):148-56. Review.

PMID:
11815711
4.

Co-expression of vascular endothelial growth factor and neuropilin-1 in ovine feto-placental artery endothelial cells.

Tsoi SC, Wen Y, Chung JY, Chen D, Magness RR, Zheng J.

Mol Cell Endocrinol. 2002 Oct 31;196(1-2):95-106.

PMID:
12385828
5.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

PMID:
12644537
6.
7.

Vascular endothelial growth factor and the regulation of angiogenesis.

Ferrara N.

Recent Prog Horm Res. 2000;55:15-35; discussion 35-6. Review.

PMID:
11036931
8.

Signaling pathways induced by vascular endothelial growth factor (review).

Larrivée B, Karsan A.

Int J Mol Med. 2000 May;5(5):447-56. Review.

PMID:
10762646
9.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
10.

The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

Robinson CJ, Stringer SE.

J Cell Sci. 2001 Mar;114(Pt 5):853-65. Review.

11.

A paracrine loop in the vascular endothelial growth factor pathway triggers tumor angiogenesis and growth in multiple myeloma.

Vacca A, Ria R, Ribatti D, Semeraro F, Djonov V, Di Raimondo F, Dammacco F.

Haematologica. 2003 Feb;88(2):176-85.

12.

Vascular endothelial growth factors and angiogenesis in eye disease.

Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO.

Prog Retin Eye Res. 2003 Jan;22(1):1-29. Review.

PMID:
12597922
13.

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.

Dias S, Hattori K, Heissig B, Zhu Z, Wu Y, Witte L, Hicklin DJ, Tateno M, Bohlen P, Moore MA, Rafii S.

Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10857-62.

15.

Quantitative analysis of gene expressions of vascular endothelial growth factor-related factors and their receptors in renal cell carcinoma.

Tsuchiya N, Sato K, Akao T, Kakinuma H, Sasaki R, Shimoda N, Satoh S, Habuchi T, Ogawa O, Kato T.

Tohoku J Exp Med. 2001 Oct;195(2):101-13.

16.

VEGF receptor signaling in tumor angiogenesis.

McMahon G.

Oncologist. 2000;5 Suppl 1:3-10. Review.

17.

Double target for tumor mass destruction.

Saharinen P, Alitalo K.

J Clin Invest. 2003 May;111(9):1277-80. No abstract available.

18.

The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor.

Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, Manseau EJ, Dasgupta PS, Dvorak HF, Mukhopadhyay D.

Nat Med. 2001 May;7(5):569-74.

PMID:
11329058
20.

Vascular endothelial growth factor gene expression regulated by protein kinase C pathway in endothelial cells during hypoxia.

Zhou Z, Yang XM, Xie YZ, Yin ZY.

Space Med Med Eng (Beijing). 2002 Oct;15(5):322-6.

PMID:
12449134

Supplemental Content

Support Center